内镜鼻窦手术患者的阿片类药物处方模式与使用情况
该回顾性病历回顾纳入2017年5月至2018年5月接受内镜鼻窦手术的155例患者,分析阿片类药物处方模式及患者报告的使用情况。94.8%患者获阿片处方,平均每人15.6片;有MassPAT数据的116例中91.4%取药;报告用量的67例中73.1%未使用阿片类药物。
要点
- 94.8%接受内镜鼻窦手术的患者获得阿片类药物处方,平均每人15.6片。
- 有MassPAT数据的116例中91.4%取药,但报告用量的67例中73.1%未使用任何阿片类药物。
- 初次手术者平均处方片数高于修正手术者(16.5 vs 13.5,P=0.0111),放置夹板者高于未放置者(21.5 vs 15.1,P=0.0037)。
核心结论
- 几乎所有接受内镜鼻窦手术的患者被开具阿片类药物处方,且几乎所有患者取了药,但绝大多数患者术后疼痛控制不需要任何阿片类药物。
研究设计与样本
- 回顾性病历回顾,纳入2017年5月至2018年5月期间接受内镜鼻窦手术的患者155例。
主要发现
- 155例中94.8%获得阿片类药物处方,平均每人15.6片。
- 有MassPAT数据的116例中91.4%取了处方。
- 报告首次随访时已用片数的67例中73.1%报告未使用阿片类药物。
- 初次手术者平均处方片数显著高于修正手术者(16.5 vs 13.5,P=0.0111),放置夹板者显著高于未放置者(21.5 vs 15.1,P=0.0037)。
- 同时行下鼻甲减容术者阿片使用率为58.3% vs 未行者14.3%(P<0.0001),同时行鼻中隔成形术者为45.5% vs 未行者21.6%(P=0.039)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Opioid-related deaths in the United States have increased 200% since 2000, in part due to prescription diversion from patients who had a surgical procedure. The purpose of this study was to characterize provider prescription patterns and assess patient-reported opioid use after endoscopic sinus surgery (ESS). STUDY DESIGN: Retrospective chart review. METHODS: Patients who underwent ESS between May 2017 and May 2018 were included. Opioid prescription, operative details, and postoperative opioid use data were extracted. The Massachusetts Prescription Awareness Tool (MassPAT) was queried to determine if patients filled their prescription. RESULTS: One hundred fifty-five patients were included. Nearly all patients received an opioid prescription (94.8%). An average of 15.6 tablets was prescribed per patient. Among 116 patients with MassPAT data, 91.4% filled their prescription. Among 67 patients who reported the number of tablets they had used at the time of first follow-up appointment, 73.1% reported taking no opioids. Mean number of tablets prescribed was significantly greater among patients who underwent primary versus revision surgery (16.5 vs. 13.5, P = .0111) and those who had splints placed (21.5 vs. 15.1, P = .0037). Predictors of opioid use included concurrent turbinate reduction (58.3% vs. 14.3%, P < .0001) and concurrent septoplasty (45.5% vs. 21.6%, P = .039). CONCLUSIONS: Nearly all patients who underwent ESS were prescribed an opioid, and nearly all patients filled their prescription. However, the vast majority of patients did not require any opioid medication for postoperative pain control. As the opioid epidemic continues to persist, these findings have immediate relevance to current prescribing patterns and pain management practices. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:1046-1052, 2019.
引用
- Sethi RKV, Miller AL, Bartholomew RA, et al. Opioid prescription patterns and use among patients undergoing endoscopic sinus surgery. Laryngoscope. 2018. PMID: 30582624. doi:10.1002/lary.27672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。